Education
About Us
Working with TipRanks
Follow Us
Bio-Techne (TECH)
NASDAQ:TECH
TECH Analyst Ratings
Moderate Buy
10 Buy
4 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
TECH Stock 12 Month Forecast
Average Price Target
$63.91
▲(26.76% Upside)
| Highest Price Target$75.00 | Average Price Target$63.91 | Lowest Price Target$53.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Scotiabank
$75
Buy
48.75%
Upside
Reiterated
08/08/25
Robert W. Baird
$58→$53
Hold
5.12%
Upside
Reiterated
08/07/25
KeyBanc
―
Hold
―
Reiterated
08/07/25
Stifel Nicolaus
$60
Hold
19.00%
Upside
Reiterated
08/07/25
RBC Capital
$63→$61
Hold
20.98%
Upside
Reiterated
08/07/25
Wells Fargo
$59
Buy
17.02%
Upside
Reiterated
08/06/25
TD Cowen
$65
Buy
28.92%
Upside
Initiated
08/06/25
William Blair
―
Buy
―
Reiterated
08/05/25
We are however puzzled by the price the asset was sold at (relative to Techne’s original purchase price and the size and growth of the business) and to some extent the timing given the robust growth ExoDx has been delivering. We expect to learn more about the timing and rationale behind the deal tomorrow morning when Techne reports its fiscal fourth- quarter results. We rate the stock Outperform (full stock thoughts in the note). Blair | Building | 150 North Riverside Plaza | Chicago, IL 60606 | +1 312 236 1600 | www.williamblair.com This is not in any sense a solicitation or offer of the purchase or sale of securities. The factual statements herein have been taken from sources we believe to be reliable, but such statements are made without any representation as to accuracy or completeness or otherwise.
Leerink Partners
―
Buy
―
Reiterated
08/05/25
Stephens
$65
Buy
28.92%
Upside
Initiated
07/21/25
Benchmark Co.
$75
Buy
48.75%
Upside
Reiterated
06/05/25
Argus Research
$90→$65
Buy
28.92%
Upside
Reiterated
05/30/25
Evercore ISI
$75
Buy
48.75%
Upside
Initiated
03/18/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Scotiabank
$75
Buy
48.75%
Upside
Reiterated
08/08/25
Robert W. Baird
$58→$53
Hold
5.12%
Upside
Reiterated
08/07/25
KeyBanc
―
Hold
―
Reiterated
08/07/25
Stifel Nicolaus
$60
Hold
19.00%
Upside
Reiterated
08/07/25
RBC Capital
$63→$61
Hold
20.98%
Upside
Reiterated
08/07/25
Wells Fargo
$59
Buy
17.02%
Upside
Reiterated
08/06/25
TD Cowen
$65
Buy
28.92%
Upside
Initiated
08/06/25
William Blair
―
Buy
―
Reiterated
08/05/25
We are however puzzled by the price the asset was sold at (relative to Techne’s original purchase price and the size and growth of the business) and to some extent the timing given the robust growth ExoDx has been delivering. We expect to learn more about the timing and rationale behind the deal tomorrow morning when Techne reports its fiscal fourth- quarter results. We rate the stock Outperform (full stock thoughts in the note). Blair | Building | 150 North Riverside Plaza | Chicago, IL 60606 | +1 312 236 1600 | www.williamblair.com This is not in any sense a solicitation or offer of the purchase or sale of securities. The factual statements herein have been taken from sources we believe to be reliable, but such statements are made without any representation as to accuracy or completeness or otherwise.
Leerink Partners
―
Buy
―
Reiterated
08/05/25
Stephens
$65
Buy
28.92%
Upside
Initiated
07/21/25
Benchmark Co.
$75
Buy
48.75%
Upside
Reiterated
06/05/25
Argus Research
$90→$65
Buy
28.92%
Upside
Reiterated
05/30/25
Evercore ISI
$75
Buy
48.75%
Upside
Initiated
03/18/25
Best Analysts Covering Bio-Techne
1 Month
xxx
Success Rate
9/15 ratings generated profit
Average Return
+2.71%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 60.00% of your transactions generating a profit, with an average return of +2.71% per trade.
3 Months
xxx
Success Rate
10/15 ratings generated profit
Average Return
+1.09%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +1.09% per trade.
1 Year
Success Rate
6/7 ratings generated profit
Average Return
+10.56%
reiterated a buy rating 5 days ago
Copying Dan Leonard's trades and holding each position for 1 Year would result in 85.71% of your transactions generating a profit, with an average return of +10.56% per trade.
2 Years
xxx
Success Rate
4/9 ratings generated profit
Average Return
-0.44%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 44.44% of your transactions generating a profit, with an average return of -0.44% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
TECH Analyst Recommendation Trends
Rating
Apr 25
May 25
Jun 25
Jul 25
Aug 25
Strong Buy
1
3
4
3
1
Buy
11
11
10
19
18
Hold
9
8
11
7
9
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
21
22
25
29
28
Each month's total comprises the sum of three months' worth of ratings.
TECH Financial Forecast
TECH Stock Forecast FAQ
What is TECH’s average 12-month price target, according to analysts?
Based on analyst ratings, Bio-Techne’s 12-month average price target is 63.91.
What is TECH’s upside potential, based on the analysts’ average price target?
Bio-Techne has 26.76% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is TECH a Buy, Sell or Hold?
Bio-Techne has a consensus rating of Moderate Buy which is based on 10 buy ratings, 4 hold ratings and 0 sell ratings.
What is Bio-Techne’s price target?
The average price target for Bio-Techne is 63.91. This is based on 14 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $75.00 ,the lowest forecast is $53.00. The average price target represents 26.76% Increase from the current price of $50.42.
The highest analyst price target is $75.00 ,the lowest forecast is $53.00. The average price target represents 26.76% Increase from the current price of $50.42.
What do analysts say about Bio-Techne?
Bio-Techne’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 14 Wall Streets Analysts.
How can I buy shares of TECH?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.